Natick

Pharmaceutical startup Karyopharm Therapeutics of Natick said underwriters for its initial public offering of common stock have exercised their option to buy more than a million additional shares.

U.S regulators said Monday that the surgery required to implant Boston Scientific's anti-stroke device might reduce its effectiveness and said more careful review is needed before making an approval decision.

Parcell Laboratories, a Natick-based provider of stem cell therapeutics, announced it has received a patent on its Early Lineage Adult (ELA) stem cell platform.

Natick-based Boston Scientific Corp. has received approval from the U.S. Food and Drug Administration (FDA) on its new stent system designed to treat coronary heart disease.

Natick-based technology storage provider Nasuni has secured a U.S. patent that covers its core technology, the ability to create a versioned file system from the object-based storage infrastructure of public cloud storage providers, the company said today.

Karyopharm Therapeutics, a Natick-based clinical-stage pharmaceutical startup, has raised $108.8 million through an initial public offering of stock Wednesday.

Boston Scientific has completed its acquisition of a division of the Lowell-based electrophysiology business of C.R. Bard, which the Natick-based medical device manufacturer said could significantly boost its capabilities in the fast-growing market for advanced electrophysiology procedures.

The Patrick administration has awarded more than $240,000 in grants to Central Massachusetts communities to boost composting, recycling and waste reduction.

Natick-based Cognex Corp. announced record profits and revenues for its third quarter.

A day after it said it would cut up to 1,500 jobs over the next two years, and on the same day it announced a third-quarter loss of $5 million, Boston Scientific said its chief financial officer will leave after the end of the year.